Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials
- PMID: 19631869
- PMCID: PMC2759770
- DOI: 10.1016/j.jvs.2009.01.012
Under-representation of women and ethnic minorities in vascular surgery randomized controlled trials
Abstract
Objectives: Gender and ethnicity are factors affecting the incidence and severity of vascular disease as well as subsequent treatment outcomes. Although well studied in other fields, balanced enrollment of patients with relevant demographic characteristics in vascular surgery randomized controlled trials (RCTs) is not well known. This study describes the reporting of gender and ethnicity data in vascular surgery RCTs and analyzes whether these studies adequately represent our diverse patient population.
Methods: We conducted a retrospective review of United States-based RCTs from 1983 through 2007 for three broadly defined vascular procedures: aortic aneurysm repair (AAR), carotid revascularization (CR), and lower extremity revascularization (LER). Included studies were examined for gender and ethnicity data, study parameters, funding source, and geographic region. The Nationwide Inpatient Sample (NIS) database was analyzed to obtain group-specific procedure frequency as an estimate of procedure frequency in the general population.
Results: We reviewed 77 studies, and 52 met our inclusion criteria. Only 85% reported gender, and 21% reported ethnicity. Reporting of ethnicity was strongly associated with larger (>280 participants), multicenter, government-funded trials (P < .001 for all). Women are disproportionately under-represented in RCTs for all procedure categories (AAR, 9.0% vs 21.5%; CR, 30.0% vs 42.9%; LER, 22.4% vs 41.3%). Minorities are under-represented in AAR studies (6.0% vs 10.7%) and CR studies (6.9% vs 9.5%) but are over-represented in LER studies (26.0% vs 21.8%, P < .001 for all).
Conclusions: Minority ethnicity and female gender are under-reported and under-represented in vascular surgery RCTs, particularly in small, non-government-funded and single-center trials. The generalizability of some trial results may not be applicable to these populations. Greater effort to enroll a balanced study population in RCTs may yield more broadly applicable results.
Figures
Similar articles
-
Reporting and representation of race/ethnicity in published randomized trials.Am Heart J. 2009 Nov;158(5):742-7. doi: 10.1016/j.ahj.2009.08.018. Epub 2009 Sep 29. Am Heart J. 2009. PMID: 19853691
-
Inclusion, analysis, and reporting of sex and race/ethnicity in clinical trials: have we made progress?J Womens Health (Larchmt). 2011 Mar;20(3):315-20. doi: 10.1089/jwh.2010.2469. Epub 2011 Feb 25. J Womens Health (Larchmt). 2011. PMID: 21351877 Free PMC article.
-
Minority Representation in Migraine Treatment Trials.Headache. 2017 Mar;57(3):525-533. doi: 10.1111/head.13018. Epub 2017 Jan 27. Headache. 2017. PMID: 28127754 Review.
-
Demographic Characteristics of Participants in Rheumatoid Arthritis Randomized Clinical Trials: A Systematic Review.JAMA Netw Open. 2019 Nov 1;2(11):e1914745. doi: 10.1001/jamanetworkopen.2019.14745. JAMA Netw Open. 2019. PMID: 31722023 Free PMC article.
-
Lack of diversity in orthopaedic trials conducted in the United States.J Bone Joint Surg Am. 2014 Apr 2;96(7):e56. doi: 10.2106/JBJS.M.00531. J Bone Joint Surg Am. 2014. PMID: 24695933 Review.
Cited by
-
Diversity in randomized clinical trials for peripheral artery disease: a systematic review.Int J Equity Health. 2024 Feb 13;23(1):29. doi: 10.1186/s12939-024-02104-8. Int J Equity Health. 2024. PMID: 38350973 Free PMC article.
-
A framework for integrating artificial intelligence for clinical care with continuous therapeutic monitoring.Nat Biomed Eng. 2023 Nov 6. doi: 10.1038/s41551-023-01115-0. Online ahead of print. Nat Biomed Eng. 2023. PMID: 37932379 Review.
-
Low-intensity resistance exercise with blood flow restriction for patients with claudication: A randomized controlled feasibility trial.Vasc Med. 2023 Dec;28(6):554-563. doi: 10.1177/1358863X231200250. Epub 2023 Oct 11. Vasc Med. 2023. PMID: 37819259 Free PMC article. Clinical Trial.
-
Outcomes among patients with peripheral artery disease in the Aspirin Dosing: A Patient-Centric Trial Assessing Benefits and Long-Term Effectiveness (ADAPTABLE) study.Vasc Med. 2023 Apr;28(2):122-130. doi: 10.1177/1358863X231154951. Vasc Med. 2023. PMID: 37025023 Free PMC article. Clinical Trial.
-
Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis.BMC Med. 2023 Mar 29;21(1):111. doi: 10.1186/s12916-023-02809-7. BMC Med. 2023. PMID: 36978166 Free PMC article.
References
-
- Kullo IJ, Bailey KR, Kardia SL, Mosley TH, Jr, Boerwinkle E, Turner ST. Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study. Vasc Med. 2003;8(4):237–42. - PubMed
-
- Sosin MD, Bhatia GS, Lip GY, Davis RC. Drug development and the importance of ethnicity: lessons from heart failure management and implications for hypertension. Curr Pharm Des. 2004;10(29):3569–77. - PubMed
-
- Chew DK, Nguyen LL, Owens CD, Conte MS, Whittemore AD, Gravereaux EC, et al. Comparative analysis of autogenous infrainguinal bypass grafts in African Americans and Caucasians: the association of race with graft function and limb salvage. J Vasc Surg. 2005;42(4):695–701. - PubMed
-
- Criqui MH, Vargas V, Denenberg JO, Ho E, Allison M, Langer RD, et al. Ethnicity and peripheral arterial disease: the San Diego Population Study. Circulation. 2005;112(17):2703–7. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous
